相关实验视频
Updated: Jun 28, 2025

06:52
Induction of Mouse Lung Injury by Endotracheal Injection of Bleomycin
Published on: April 30, 2019
17.4K
在肺纤维化中,B-1细胞和氧化特异性表位体IgM的保护作用
bioRxiv : the preprint server for biology
|April 25, 2024
概括
B-1细胞分泌IgM,该IgM向氧化特异性表位,减少小鼠模型中的肺纤维化. 这一发现为异常性肺纤维化 (IPF) 提供了新的治疗途径.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部医学 肺部医学
- 纤维化研究 纤维化研究
背景情况:
- 异形性肺纤维化 (IPF) 是一种严重的肺部疾病,原因不明,治疗方法有限.
- B-1细胞是一种先天性免疫细胞,产生天然的IgM抗体,可以向氧化特异性表位 (OSE).
- OSE与肺损伤和纤维化有关,B-1细胞位于纤维化肺部区域附近.
研究的目的:
- 研究B-1细胞及其IgM在肺纤维化病原发生中的作用.
- 探索B-1细胞被招募和调节纤维化的机制.
- 在肺损伤模型中评估针对OSE的IgM治疗潜力.
主要方法:
- 研究了B-1细胞向肺部招募和IgM分泌作为对受伤的反应.
- 研究了B-1细胞中转录因子Id3对化学因子受体CXCR4的调节.
- 在白素诱导的肺纤维化模型中使用了缺少Id3的小鼠和分泌IgM的小鼠.
- 通过气道输送进行的针对OSE的IgM (IgMOSE E06).
- 进行RNA测序和途径分析以阐明IgM的抗纤维机制.
主要成果:
- B-1细胞被招募到受伤的肺部,并分泌出针对OSE的IgM.
- 转录因子Id3在B-1细胞上负面调节CXCR4的表达.
- 特定于B-1细胞的Id3缺乏导致了白血素诱导的肺纤维化减少.
- 分泌IgM缺乏的小鼠在白色胺素损伤后死亡率增加,这种损伤在IgMOSEE06给药后被部分挽救.
- RNA测序显示,IgM影响补充激活和细胞外矩阵沉积途径.
结论:
- B-1细胞及其IgMOSE在缓解肺纤维化方面起着保护作用.
- Id3是肺损伤中B-1细胞功能的新型调节剂.
- IgMOSE代表了治疗或预防肺纤维化的潜在治疗策略.
相关概念视频
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
2.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
2.8K
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K

